Oracle Health Sciences announced the availability of Oracle Health Sciences OutcomeLogix On Demand 3.0 a Web-based, scalable data collection system that enables life science companies and contract research organizations (CROs) to efficiently capture accurate therapy outcome information from health care providers, as well as patients in late-stage studies.
The newest version of the solution incorporates several features that help meet increasing requirements to improve product safety and demonstrate long-term treatment efficacy. New capabilities that address the increasingly larger, geographically dispersed, and patient-centered nature of observational studies include:
Featuring a flexible, Web-based architecture, Oracle Health Sciences OutcomeLogix On Demand 3.0 can be deployed quickly and easily to large numbers of sites and patients.
Oracle Health Sciences OutcomeLogix On Demand 3.0 is part of a comprehensive portfolio of Oracle Health Sciences Cloud Applications and is powered by the Oracle Health Sciences Cloud to help customers accelerate IT deployments, reduce resources required to maintain IT infrastructure, and gain a more predictable IT spending pattern.
AI in Clinical Trials: A Long, But Promising Road Ahead
May 29th 2024Stephen Pyke, chief clinical data and digital officer, Parexel, discusses how AI can be used in clinical trials to streamline operational processes, the importance of collaboration and data sharing in advancing the use of technology, and more.
Including Women of Childbearing Age in Clinical Research
March 26th 2024In recognition of International Women's Month, we're featuring this recent talk between Associate Editor Miranda Schmalfuhs and Marie Teil, Global Head of UCB’s Women of Childbearing Age Program. They speak about the specific challenges women with chronic illnesses face when accessing appropriate treatment and participating in clinical trials, UCB's Women of Childbearing Age Program and it’s most successful strategies, and much more.
Ethical, Biosafety, and Scientific Review Considerations in Hematology and Oncology Clinical Trials
September 10th 2024The current oncology and hematology drug development pipeline features a wide array of large molecule therapeutics. As a result, clinical trial protocols have grown more complex, requiring sponsors, CROs, and research sites to tackle a variety of challenges that were less common with older, more traditional therapies.